Prevention & risk

The Mitchell Institute’s prevention & risk team focuses on improving our health system so more Australians can engage with and benefit from the service, supporting a healthier, fairer and more productive society.

We lead the Australian Health Policy Collaboration which brings together more than 60 leading health organisations and chronic disease experts to translate rigorous research into good policy. The national collaboration has developed health targets and indicators for preventable chronic diseases designed to contribute to reducing the health impacts of chronic conditions on the Australian population.

Key contacts

Rosemary Calder

Professor of Health Policy, Institute of Health & Sport

Maximilian de Courten

Vice-Chancellor's Distinguished Research Fellow (VCDRF)

Vaccination disparities risk further entrenching disadvantage

8 October 2021

The Conversation: With vaccination rates generally lower among low socioeconomic groups, post lockdown social and economic privileges for the fully vaccinated is likely to increase inequality.

New mental health roadmap to stop the 23 year death gap

26 August 2021

A new AHPC recommends major improvements to primary healthcare services in Australia to stop people with serious mental illnesses from dying between 14 and 23 years earlier than other Australians.

Improving mental health of young people in tertiary education

25 August 2021

Each year, over 200,000 university students aged 18-25 years old will experience mental ill health. Young people have the highest prevalence of mental health disorders or behavioural conditions of all age groups.

mRNA licence & vaccine facility urgently needed

26 July 2021

The Federal Government needs to licence and produce an mRNA vaccine in Australia immediately to avoid an ongoing shortage of COVID-19 vaccine and frequent lockdowns, according to the Mitchell Institute

We probably can't eliminate COVID in Australia forever

7 July 2021

The Conversation: Moving away from an elimination approach to a long-term management strategy requires us to rapidly vaccinate most of the population, as vaccination significantly reduces severe outcomes from COVID.

Condoms, vaccines & sport: how the Tokyo Olympics is sending mixed messages about COVID-19 safety

5 July 2021

The Conversation: The Tokyo Olympics are less than three weeks away. And the pressure is on for the International Olympic Committee (IOC).

Stopping, blocking & dampening – how Aussie drugs in the pipeline could treat COVID-19

24 June 2021

The Conversation: While widespread vaccination is key in our fight against COVID-19, people who are infected still need better treatment to improve their chance of survival and making a full recovery.

COVID is surging in unvaccinated Taiwan. Australia should take heed

24 May 2021

The Conversation: Alarm bells rang internationally last week when Taiwan announced it was moving to its second highest COVID alert level after a recent surge of cases.

What is thrombocytopenia, the rare blood condition possibly linked to the AstraZeneca vaccine?

8 April 2021

The government has asked Australia’s medical and vaccine regulators to urgently consider the European Medicines Agency’s finding of a possible link between the Oxford/AstraZeneca COVID vaccine and rare blood clots.

About

Health

Education